American International Group, Inc. Prometheus Biosciences, Inc. Transaction History

American International Group, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$103.46 - $126.29 $34,555 - $42,180	334 Added 2.03%	16,793 $1.8 Million
Q4 2022 Feb 10, 2023	BUY	$36.06 - $117.21 $69,415 - $225,629	1,925 Added 13.24%	16,459 $1.81 Million
Q3 2022 Nov 14, 2022	BUY	$28.17 - $59.01 $23,550 - $49,332	836 Added 6.1%	14,534 $858,000
Q2 2022 Aug 12, 2022	SELL	$22.39 - $38.94 $26,464 - $46,027	-1,182 Reduced 7.94%	13,698 $387,000
Q1 2022 May 13, 2022	SELL	$30.13 - $50.0 $31,576 - $52,400	-1,048 Reduced 6.58%	14,880 $562,000
Q4 2021 Feb 11, 2022	BUY	$22.28 - $39.54 $217,051 - $385,198	9,742 Added 157.48%	15,928 $630,000
Q3 2021 Nov 12, 2021	SELL	$20.89 - $26.96 $3,070 - $3,963	-147 Reduced 2.32%	6,186 $147,000
Q2 2021 Aug 13, 2021	BUY	$16.8 - $29.65 $106,394 - $187,773	6,333 New	6,333 $156,000

29.6K

Ticker RXDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,904,100
Description
Prometheus Biosciences, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of novel therapeutics and companion diagnostics products for the treatment of inflammatory bowel diseases (IBD). Its lead product includes PRA023, a humanized IgG1 monoclonal antibody (mAb), which is in Phase IIa clinical trial...

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

Stay updated on American International Group, Inc. with notifications on news.